On Friday, Moleculin Biotech Inc (NASDAQ: MBRX) was 7.12% up from the session before settling in for the closing price of $0.46. A 52-week range for MBRX has been $0.25 – $3.65.
A company in the Healthcare sector has jumped its sales by 26.36% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 80.33%. With a float of $48.06 million, this company’s outstanding shares have now reached $49.50 million.
Moleculin Biotech Inc (MBRX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Moleculin Biotech Inc stocks. The insider ownership of Moleculin Biotech Inc is 8.87%, while institutional ownership is 1.35%. The most recent insider transaction that took place on Jun 23 ’25, was worth 100,000. In this transaction Chief Financial Officer of this company bought 270,270 shares at a rate of $0.37, taking the stock ownership to the 287,587 shares. Before that another transaction happened on Jun 23 ’25, when Company’s CEO and President bought 675,675 for $0.37, making the entire transaction worth $250,000. This insider now owns 743,607 shares in total.
Moleculin Biotech Inc (MBRX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -2.85 earnings per share (EPS) during the time that was less than consensus figure (set at -2.44) by -0.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.64% during the next five years compared to 26.36% growth over the previous five years of trading.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
You can see what Moleculin Biotech Inc (MBRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.59, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.05 in one year’s time.
Technical Analysis of Moleculin Biotech Inc (MBRX)
Let’s dig in a bit further. During the last 5-days, its volume was 6.5 million. That was better than the volume of 4.43 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.03%.
During the past 100 days, Moleculin Biotech Inc’s (MBRX) raw stochastic average was set at 33.66%, which indicates a significant increase from 29.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0532 in the past 14 days, which was lower than the 0.0609 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4526, while its 200-day Moving Average is $0.7744. However, in the short run, Moleculin Biotech Inc’s stock first resistance to watch stands at $0.5077. Second resistance stands at $0.5263. The third major resistance level sits at $0.5602. If the price goes on to break the first support level at $0.4552, it is likely to go to the next support level at $0.4213. The third support level lies at $0.4027 if the price breaches the second support level.
Moleculin Biotech Inc (NASDAQ: MBRX) Key Stats
There are 49,499K outstanding shares of the company, which has a market capitalization of 24.20 million. As of now, sales total 0 K while income totals -21,760 K. Its latest quarter income was 0 K while its last quarter net income were -7,640 K.
